PTLA - Portola Pharmaceuticals' (PTLA) CEO Scott Garland on Q1 2019 Results - Earnings Call Transcript
Portola Pharmaceuticals, Inc. (PTLA)
Q1 2019 Earnings Conference Call
May 8, 2019 8:30 AM ET
Company Participants
Cara Miller – Vice President-Investor Relations and Corporate Communications
Scott Garland – President and Chief Executive Officer
Sheldon Koenig – Chief Commercial Officer
John Curnutte – Head-Research and Development
Mardi Dier – Chief Financial and Chief Business Officer
Conference Call Participants
Yigal Dov Nochomovitz – Citigroup
Phil Nadeau – Cowen and Company
Jay Olson – Oppenheimer
Vamil Divan – Credit Suisse
Matt Phipps – William Blair
Vikram Purohit – Morgan Stanley
Presentation
Operator
Good day and welcome to